The Prospera SCS system for pain management relieved pain, improved sleep and reduced opioid use at 24 months, according to ...

In Restem, LLC v. Jadi Cell, LLC, No. 2023-2054 (Fed. Cir. Mar. 13, 2025), the Federal Circuit upheld the Patent Trial and ...

Researchers conducting a clinical trial of immunotherapy drugs for people with head and neck squamous cell carcinomas (HNSCCs ...

Normothermic machine perfusion was linked to significant improvements in liver transplant clinical outcomes and reduced hospital resource use, especially among patients who received donation after ...

A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to ...

CLS-AX Phase 3 Program Designed to Maximize Commercial Potential in Wet AMD -- Flexible Dosing and Extended Duration would be Important ...

Nevro Corp. NVRO reported a loss per share of 64 cents in the fourth quarter of 2024, wider than the year-ago quarter’s loss ...

Dr. Conner is the only surgeon in Connecticut performing an innovative procedure involving a facial nerve stimulator, a groundbreaking alternative for ...

The counsel argued that the transfer of civilians accused in connection with the May 9 events to military authorities violated Section 549 of the Criminal Procedure Code (CrPC), read with Section ...

The FDA approves BrainSense Adaptive deep brain stimulation and electrode identifier technology for the treatment of Parkinson disease.

Earlier, Escudero stood firm that the pre-trial procedures will commence upon resumption of sessions on June 2 and they will start trial in the 20th Congress after the State of the Nation Address of ...

Hyderabad: The negligence of police in not conducting a drunk driving test on a GHMC garbage tipper driver involved in a fatal accident in Secunderaba.